Shanghai, China

Yaozhou Shi

This inventor holds 1 USPTO granted patent. Top assignee: Shanghai Institutes for Biological Sciences, Cas. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yaozhou Shi. Retrieved from https://idiyas.com/inventor/yaozhou-shi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yaozhou Shi: Innovator in Baldness Research

Introduction

Yaozhou Shi is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of genetics, particularly in the study of baldness. His innovative work has led to the development of a patent that addresses a common concern for many individuals.

Latest Patents

Yaozhou Shi holds a patent titled "Baldness related gene and the polypeptide encoded thereby, and uses." This invention discloses a baldness-related gene and the encoded polypeptide, along with a process for producing the polypeptide through recombinant methods. Additionally, it highlights the use of the Rhor gene and protein in the diagnosis and treatment of baldness. He has 1 patent to his name.

Career Highlights

Yaozhou Shi is affiliated with the Shanghai Institutes for Biological Sciences, a leading research institution in China. His work there focuses on advancing the understanding of genetic factors related to hair loss. His research has the potential to impact the lives of many individuals suffering from baldness.

Collaborations

Some of his notable coworkers include Shanru Li and Xiangyin Kong. Their collaborative efforts contribute to the ongoing research and development in the field of genetics.

Conclusion

Yaozhou Shi's innovative research in baldness-related genetics showcases his commitment to addressing a widespread issue. His contributions to the field are significant and pave the way for future advancements in diagnosis and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…